[PDF][PDF] Targeting RTKs/nRTKs as promising therapeutic strategies for the treatment of triple-negative breast cancer: evidence from clinical trials.
The extensive heterogeneity and the limited availability of effective targeted therapies
contribute to the challenging prognosis and restricted survival observed in triple-negative …
contribute to the challenging prognosis and restricted survival observed in triple-negative …
Recent Advances in Breast Cancer Research
D Grimm - International Journal of Molecular Sciences, 2023 - mdpi.com
This Special Issue (SI), titled “Recent Advances in Breast Cancer Research”, covers 12
research articles and 1 communication in the field of breast cancer (BC) research. It includes …
research articles and 1 communication in the field of breast cancer (BC) research. It includes …
Phenotypic heterogeneity drives differential disease outcome in a mouse model of triple negative breast cancer
AP Thankamony, S Ramkomuth, ST Ramesh… - Frontiers in …, 2023 - frontiersin.org
The triple negative breast cancer (TNBC) subtype is one of the most aggressive forms of
breast cancer that has poor clinical outcome and is an unmet clinical challenge …
breast cancer that has poor clinical outcome and is an unmet clinical challenge …